Further to its announcements dated February 2 and 8, 2022, on the acquisition of German medical cannabis firm Nimbus Health GmbH by its subsidiary Reddy Holding GmbH, Dr Reddys Laboratories has informed that the acquisition has now been completed. Nimbus Health GmbH is now a wholly owned step-down subsidiary of the Company with effect from February 24, 2022. The required details under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’) read with the SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, as already disclosed to the exchanges on February 8, 2022, are enclosed as an Annexure to this intimation.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: